GTNF/Polosa: “A rigorous scientific approach to Harm Reduction is a resource”
A group of Harm Reduction experts and scientists discussed the latest news on THR during the virtual meeting GTNF In Focus: THR 2021
CoEHAR among the contributors of the Beating Cancer Plan
The Center of Excellence for the Acceleration of Harm Reduction (CoEHAR) is among the contributors for the drafting of the BECA Report by the Special Committee on Cancer of the European Parliament
Replica (CoEHAR): is there any correlation between Covid-19 and Harm Reduction?
A new study by CoEHAR, the "Role of Cigarette Smoke on Angiotensin-Converting Enzyme-2 Protein Membrane Expression in Bronchial Epithelial Cells Using an Air-Liquid Interface Model" investigates the molecular mechanisms that regulate the expression of the ACE2 enzyme, involved in Covid-19 infection
Replica Project: a new study sets quality standards for the storage conditions of nicotine samples
The new study by CoEHAR, "Nicotine dosimetry and stability in cambridge filter PADs (CFPs) following different smoking regime protocols and storage conditions", provided new guidelines for future multicentric studies in the low-risk products
Latest study by CoEHAR aims to systematically review all the studies on health effects of e-cigarette substitution
The main goal of the protocol, the research project plan, is to examine the scientific evidence on the effects of e-cigarettes on smokers from the available studies. The project includes writing a paper for doctors and health care providers, a fact sheet for people who use e-cigarettes, and a policy brief for legislators on health committees
Electronic cigarettes help smokers with schizophrenia quit
A new study in Nicotine & Tobacco Research, published by Oxford University Press, finds that the use of high-strength nicotine e-cigarettes can help adults with schizophrenia spectrum disorders quit smoking
SRNT 2021- Giovanni Li Volti: “A potential role of nicotine as a protective factor from Covid-19”
Catania February, 2021 – The Director of CoEHAR Giovanni Li Volti presented at the meeting of the Society for Research on Nicotine & Tobacco (SRNT 2021) the study “The Role of cigarette…
COVID-19 and the human body: nicotine as a “controller” of the molecular expression of ACE-2
Nicotine is a protective shield against the insurgence of severe symptoms of COVID-19. This is what emerged with the new study by CoEHAR
CoEHAR- The risk of Covid-19 transmission with vaping is negligible, equal to 1%
According to the latest study by COEHAR laboratories within the University of Catania, conducted by a group coordinated by Professor Riccardo Polosa, the risk of Covid-19 transmission with vaping is negligible, equal to 1%
CoEHAR’s research awarded on SRNT 2021 annual meeting
The Society for Research on Nicotine & Tobacco (SRNT) shortlisted the Center of Excellence for the acceleration of Harm Reduction (CoEHAR) for the 2021 edition of its annual meeting, hosted online from 24th to 27th of February
- Go to the previous page
- 1
- …
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- …
- 28
- Go to the next page
